Back to Search Start Over

Network Pharmacology- and Molecular Docking-Based Identification of Potential Phytocompounds from Argyreia capitiformis in the Treatment of Inflammation.

Authors :
Obaidullah AJ
Alanazi MM
Alsaif NA
Alanazi AS
Albassam H
Az A
Alwassil OI
Alqahtani AM
Tareq AM
Source :
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Jan 31; Vol. 2022, pp. 8037488. Date of Electronic Publication: 2022 Jan 31 (Print Publication: 2022).
Publication Year :
2022

Abstract

The methanolic extract of Argyreia capitiformis stem was examined for anti-inflammatory activities following network pharmacology analysis and molecular docking study. Based on gas chromatography-mass spectrometry (GC-MS) analysis, 49 compounds were identified from the methanolic extract of A. capitiformis stem. A network pharmacology analysis was conducted against the identified compounds, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and Gene Ontology analysis of biological processes and molecular functions were performed. Six proteins (IL1R1, IRAK4, MYD88, TIRAP, TLR4, and TRAF6) were identified from the KEGG pathway analysis and subjected to molecular docking study. Additionally, six best ligand efficiency compounds and positive control (aspirin) from each protein were evaluated for their stability using the molecular dynamics simulation study. Our study suggested that IL1R1, IRAK4, MYD88, TIRAP, TLR4, and TRAF6 proteins may be targeted by compounds in the methanolic extract of A. capitiformis stem to provide anti-inflammatory effects.<br />Competing Interests: The authors declare no conflicts of interest.<br /> (Copyright © 2022 Ahmad J. Obaidullah et al.)

Details

Language :
English
ISSN :
1741-427X
Volume :
2022
Database :
MEDLINE
Journal :
Evidence-based complementary and alternative medicine : eCAM
Publication Type :
Academic Journal
Accession number :
35140801
Full Text :
https://doi.org/10.1155/2022/8037488